STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] Ainos, Inc. Warrants Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Form 8-K – Item 8.01 Other Events

On 6-Aug-2025, Ainos, Inc. (Nasdaq: AIMD; AIMDW) reported that it has secured a US$2.1 million order from ASE Technology Holding Co., Ltd. to deploy the company’s AI Nose sensing platform in a semiconductor manufacturing environment. The related press release is provided as Exhibit 99.1.

The filing contains no revisions to previously issued financial statements, no earnings guidance, and no additional contractual terms beyond the order’s value and intended use. Other than standard cover information, Items 8.01 and 9.01 are the only sections with substantive disclosure.

Positive
  • US$2.1 million order from ASE Technology validates AI Nose platform and provides immediate contracted revenue.
Negative
  • None.

Insights

TL;DR: $2.1 M order adds incremental revenue and demonstrates early commercial traction; positive but limited visibility on profitability.

The ASE Technology purchase validates market interest in Ainos’ AI Nose platform and delivers an immediate US$2.1 million sales boost. For smaller issuers, a multi-million-dollar contract can be material to annual revenue, although the filing does not provide context on historical sales or margins. Because no fulfillment timeline, gross-margin data, or follow-on commitments are disclosed, investors cannot yet quantify earnings impact. Still, the order reduces product-commercialization risk and could support future customer wins in the semiconductor sector.

false 0001014763 0001014763 2025-08-06 2025-08-06 0001014763 AIMD:CommonStockParValue0.01PerShareMember 2025-08-06 2025-08-06 0001014763 AIMD:WarrantsToPurchaseCommonStockMember 2025-08-06 2025-08-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 6, 2025

 

AINOS, INC.
(Exact name of registrant as specified in its charter)

 

Texas   001-41461   75-1974352

(State or other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

8880 Rio San Diego Drive, Ste. 800, San Diego, CA 92108

(858) 869-2986

(Address and telephone number, including area code, of registrant’s principal executive offices)

 

(Former name or former address if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.01 per share   AIMD   The Nasdaq Stock Market LLC
Warrants to purchase Common Stock   AIMDW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01 Other Events.

 

On August 6, 2025, Ainos, Inc., a Texas corporation, issued a press release announcing that it has secured a $2.1 million order with ASE Technology Holding Co., Ltd. for the deployment of AI Nose in semiconductor manufacturing setting. A copy of the press release is furnished herewith as Exhibit 99.1.

 

Item 9.01 Financial Statement and Exhibits

 

(d) Exhibits.

 

Exhibit No.   Description
99.1   Press Release dated August 6, 2025.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Ainos, Inc.
     
Date: August 7, 2025 By: /s/ Chun-Hsien Tsai
  Name: Chun-Hsien Tsai
  Title: Chief Executive Officer

 

3

 

FAQ

What did Ainos (AIMD) announce in its 8-K dated August 6, 2025?

The company disclosed a US$2.1 million purchase order from ASE Technology Holding for its AI Nose system.

How much is the ASE Technology order worth?

The order is valued at approximately US$2.1 million.

Which Ainos product is involved in the new contract?

The purchase covers deployment of Ainos’ AI Nose sensing platform in semiconductor manufacturing.

Does the filing include updated financial statements or guidance?

No. The 8-K only furnishes the press release; it does not provide financial statements or forecasts.

Where are Ainos’ securities traded?

Ainos’ common stock trades under AIMD and its warrants under AIMDW on The Nasdaq Stock Market LLC.
AINOS INC

NASDAQ:AIMDW

AIMDW Rankings

AIMDW Latest News

AIMDW Latest SEC Filings

AIMDW Stock Data

780.00k
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO